Skip to main content
. 2023 Mar 14;12(6):2253. doi: 10.3390/jcm12062253

Figure 1.

Figure 1

Mechanism of the effects of SGLT2 inhibitors on liver cirrhosis patients with refractory ascites. ANP, atrial natriuretic peptide; AVP, arginine vasopressin.